Eva Estébanez‐Perpiñá

2.4k total citations
40 papers, 1.7k citations indexed

About

Eva Estébanez‐Perpiñá is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Estébanez‐Perpiñá has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Genetics and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Estébanez‐Perpiñá's work include Estrogen and related hormone effects (21 papers), Prostate Cancer Treatment and Research (11 papers) and Hormonal and reproductive studies (10 papers). Eva Estébanez‐Perpiñá is often cited by papers focused on Estrogen and related hormone effects (21 papers), Prostate Cancer Treatment and Research (11 papers) and Hormonal and reproductive studies (10 papers). Eva Estébanez‐Perpiñá collaborates with scholars based in Spain, United States and United Kingdom. Eva Estébanez‐Perpiñá's co-authors include Robert J. Fletterick, R. Kiplin Guy, Paul Webb, John D. Baxter, Ellena Mar, Leggy A. Arnold, Phuong Nguyen, Víctor Buzón, Pablo Fuentes‐Prior and Dorien Clarisse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Eva Estébanez‐Perpiñá

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Estébanez‐Perpiñá Spain 23 971 669 485 455 156 40 1.7k
Christine Helsen Belgium 22 890 0.9× 539 0.8× 402 0.8× 720 1.6× 176 1.1× 42 1.7k
Kevin Kish United States 20 930 1.0× 305 0.5× 384 0.8× 240 0.5× 265 1.7× 38 2.0k
Haiching Ma United States 23 1.7k 1.8× 265 0.4× 552 1.1× 194 0.4× 406 2.6× 37 3.0k
Beatrice Darimont United States 21 1.9k 1.9× 1.3k 2.0× 525 1.1× 505 1.1× 499 3.2× 30 3.0k
Mirra Chung United States 20 949 1.0× 282 0.4× 211 0.4× 207 0.5× 544 3.5× 29 1.8k
Eric Leblanc Canada 21 684 0.7× 433 0.6× 307 0.6× 679 1.5× 130 0.8× 38 1.4k
Richard Wagner United States 8 1.4k 1.4× 1.5k 2.3× 663 1.4× 103 0.2× 210 1.3× 8 2.2k
George F. Allan United States 22 957 1.0× 1.2k 1.8× 459 0.9× 119 0.3× 171 1.1× 46 2.0k
Scott J. Novick United States 22 1.3k 1.3× 310 0.5× 81 0.2× 77 0.2× 242 1.6× 41 1.9k
Susan E. Kiefer United States 14 622 0.6× 226 0.3× 200 0.4× 182 0.4× 163 1.0× 21 1.4k

Countries citing papers authored by Eva Estébanez‐Perpiñá

Since Specialization
Citations

This map shows the geographic impact of Eva Estébanez‐Perpiñá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Estébanez‐Perpiñá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Estébanez‐Perpiñá more than expected).

Fields of papers citing papers by Eva Estébanez‐Perpiñá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Estébanez‐Perpiñá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Estébanez‐Perpiñá. The network helps show where Eva Estébanez‐Perpiñá may publish in the future.

Co-authorship network of co-authors of Eva Estébanez‐Perpiñá

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Estébanez‐Perpiñá. A scholar is included among the top collaborators of Eva Estébanez‐Perpiñá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Estébanez‐Perpiñá. Eva Estébanez‐Perpiñá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fettweis, Grégory, Kaustubh Wagh, Diana A. Stavreva, et al.. (2025). Transcription factors form a ternary complex with NIPBL/MAU2 to localize cohesin at enhancers. Nucleic Acids Research. 53(9). 2 indexed citations
2.
Johnson, Thomas A., Montserrat Abella, Sohyoung Kim, et al.. (2025). The multimerization pathway of the glucocorticoid receptor. Nucleic Acids Research. 53(19).
3.
Estébanez‐Perpiñá, Eva, et al.. (2025). Phosphorylation-Regulated Conformational Diversity and Topological Dynamics of an Intrinsically Disordered Nuclear Receptor. The Journal of Physical Chemistry B. 129(30). 7719–7730. 1 indexed citations
4.
Fuentes‐Prior, Pablo, et al.. (2024). Androgen receptor post-translational modifications and their implications for pathology. Biochemical Society Transactions. 52(4). 1673–1694.
5.
Poulard, Coralie, Montserrat Abella, Rosa Antón, et al.. (2023). A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance. Science Advances. 9(11). eade2175–eade2175. 12 indexed citations
6.
Fettweis, Grégory, Montserrat Abella, Rosa Antón, et al.. (2022). The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities. Nucleic Acids Research. 50(22). 13063–13082. 19 indexed citations
7.
Estébanez‐Perpiñá, Eva, Charlotte L. Bevan, & Iain J. McEwan. (2021). Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on. Cancers. 13(3). 509–509. 31 indexed citations
8.
Bosscher, Karolien De, Sofie Desmet, Dorien Clarisse, Eva Estébanez‐Perpiñá, & Luc Brunsveld. (2020). Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation. Nature Reviews Endocrinology. 16(7). 363–377. 146 indexed citations
9.
Szulc, Elzbieta, Claudio Di Sanza, Paula Martínez-Cristóbal, et al.. (2017). Regulation of Androgen Receptor Activity by Transient Interactions of Its Transactivation Domain with General Transcription Regulators. Structure. 26(1). 145–152.e3. 35 indexed citations
10.
Preković, Stefan, Nerea Gallastegui, Christine Helsen, et al.. (2017). Structure of the homodimeric androgen receptor ligand-binding domain. Nature Communications. 8(1). 14388–14388. 140 indexed citations
11.
Cato, Laura, Antje Neeb, Claudia Muhle‐Goll, et al.. (2014). Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif. Journal of Biological Chemistry. 289(13). 8839–8851. 40 indexed citations
12.
Gallastegui, Nerea, et al.. (2014). Advances in our structural understanding of orphan nuclear receptors. Trends in Biochemical Sciences. 40(1). 25–35. 49 indexed citations
13.
Gallastegui, Nerea, et al.. (2014). Allosteric mechanisms of nuclear receptors: insights from computational simulations. Molecular and Cellular Endocrinology. 393(1-2). 75–82. 22 indexed citations
14.
Estruch, Sara B., et al.. (2012). The Oncoprotein BCL11A Binds to Orphan Nuclear Receptor TLX and Potentiates its Transrepressive Function. PLoS ONE. 7(6). e37963–e37963. 26 indexed citations
15.
Buzón, Víctor, et al.. (2011). A conserved surface on the ligand binding domain of nuclear receptors for allosteric control. Molecular and Cellular Endocrinology. 348(2). 394–402. 74 indexed citations
16.
Estébanez‐Perpiñá, Eva, Leggy A. Arnold, Marie Togashi, et al.. (2007). Structural Insight into the Mode of Action of a Direct Inhibitor of Coregulator Binding to the Thyroid Hormone Receptor. Molecular Endocrinology. 21(12). 2919–2928. 49 indexed citations
17.
Estébanez‐Perpiñá, Eva, et al.. (2007). Perspectives on designs of antiandrogens for prostate cancer. Expert Opinion on Drug Discovery. 2(10). 1341–1355. 9 indexed citations
18.
Estébanez‐Perpiñá, Eva, Jamie Moore, Ellena Mar, et al.. (2004). The Molecular Mechanisms of Coactivator Utilization in Ligand-dependent Transactivation by the Androgen Receptor. Journal of Biological Chemistry. 280(9). 8060–8068. 126 indexed citations
19.
Estébanez‐Perpiñá, Eva, Pablo Fuentes‐Prior, Didier Belorgey, et al.. (2002). Caspase activator human granzyme B, crystal structure and implications in apoptosis. Acta Crystallographica Section A Foundations of Crystallography. 58(s1). c280–c280. 1 indexed citations
20.
Estébanez‐Perpiñá, Eva, et al.. (2002). The 2.2-Å Crystal Structure of Human Pro-granzyme K Reveals a Rigid Zymogen with Unusual Features. Journal of Biological Chemistry. 277(52). 50923–50933. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Helsen Breakdown of academic impact, for papers by Kevin Kish Breakdown of academic impact, for papers by Haiching Ma Breakdown of academic impact, for papers by Beatrice Darimont Breakdown of academic impact, for papers by Mirra Chung Breakdown of academic impact, for papers by Eric Leblanc Breakdown of academic impact, for papers by Richard Wagner Breakdown of academic impact, for papers by George F. Allan Breakdown of academic impact, for papers by Scott J. Novick Breakdown of academic impact, for papers by Susan E. Kiefer
Rankless by CCL
2026